| Recruiting | FAPO-2: Cardiac Patient Monitoring Tool for Clinical Observation and Arrhythmia Detection NCT07174206 | University of Sao Paulo | N/A |
| Enrolling By Invitation | The Influence of Modifying Highly Calcified Coronary Lesions on Coronary Microcirculation NCT06507449 | Medical University of Silesia | N/A |
| Unknown | Atherosclerotic Lesion Proteomics by Harvesting Angioplasty Balloons (ALPHA). NCT05319366 | Rigshospitalet, Denmark | — |
| Recruiting | COMPLEX Registry - a Prospective COhort Study to Describe the Management and Outcomes of Patients Presenting w NCT06075602 | Luzerner Kantonsspital | — |
| Recruiting | SIROOP Registry - A Prospective Registry Study to Evaluate the Outcomes of Coronary Artery Disease Patients Tr NCT04988685 | Luzerner Kantonsspital | — |
| Completed | Dapagliflozin Effects on Mayor Adverse Cardiovascular Events in Patients With Acute Myocardial Infarction (DAP NCT04717986 | Instituto Mexicano del Seguro Social | N/A |
| Completed | Compressive Elastic Dressing Versus TR Band NCT05409716 | An-Najah National University | N/A |
| Unknown | Distal Radial Access for Coronary Procedures NCT06165406 | Hospital Arnau de Vilanova | — |
| Completed | Distal vs. Forearm Radial Artery Access NCT04125992 | An-Najah National University | N/A |
| Completed | Rehabilitation After Acute Coronary Syndrome: a New Telemonitoring Strategy NCT04942977 | Catcronic Salut SL | N/A |
| Completed | Assessing the Accuracy of the OptoWire DeuxTM in a Wire to Wire Comparison NCT03815032 | Centre hospitalier de l'Université de Montréal (CHUM) | N/A |
| Completed | Contrast-associated Acute Kidney Injury in Patients With Different Types of Coronary Artery Disease NCT04163484 | I.M. Sechenov First Moscow State Medical University | — |
| Unknown | Trimetazidine in Myocardial Injury After Percutaneous Coronary Intervention in Patients With Angina and Diabet NCT03715582 | University of Sao Paulo General Hospital | Phase 3 |
| Completed | Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xience Sierra Everolimus-eluting St NCT04475380 | Foundation of Cardiovascular Research and Education Enschede | — |
| Completed | Physiologic Assessment of Coronary Stenosis Following PCI NCT03084367 | Volcano Corporation | — |
| Completed | Time Gain in the Diagnosis Myocardial Infarction by Troponin Point of Care Testing in the Emergency Room NCT02972814 | Ziekenhuis Oost-Limburg | — |
| Completed | One-hour Troponin in a Low-prevalence Population of Acute Coronary Syndrome NCT02983123 | Oslo University Hospital | — |
| Completed | Crushed Ticagrelor Versus Eptifibatide Bolus + Clopidogrel NCT02925923 | University of Alabama at Birmingham | Phase 2 |
| Unknown | OCT Based Edge and In-stent Vascular Response After Cordimax Stent in patIents With NSTE-ACS NCT02868203 | Xijing Hospital | Phase 4 |
| Unknown | Randomized Trial of COBRA PzF Stenting to Reduce Duration of Triple Therapy NCT02594501 | CeloNova BioSciences, Inc. | N/A |
| Completed | Intracoronary Thrombus Detection by Magnetic Resonance Imaging NCT02776657 | University of Edinburgh | N/A |
| Unknown | Drug Eluting Balloon for Treatment of Unstable Angina NCT02760732 | Yun Dai Chen | N/A |
| Completed | Optimal Lesion Preparation With Non-compliant Balloons Before Implantation Of Bioresorbable Scaffolds NCT03518645 | KCRI | N/A |
| Unknown | Efficacy Study of Nicorandil on Neointima NCT02328521 | Zhang Ying Qian | Phase 4 |
| Completed | Determination of the Role of Oxygen in Suspected Acute Myocardial Infarction by Biomarkers NCT02290080 | Karolinska Institutet | Phase 3 |
| Completed | Antiplatelet Therapy Following Stent Implantation NCT02051361 | Elpen Pharmaceutical Co. Inc. | — |
| Terminated | Routine Versus Selective Use of FFR to Guide PCI NCT02000661 | Cardiology Research UBC | Phase 4 |
| Completed | An Efficacy and Outcome Study of Supplemental Oxygen Treatment in Patients With Suspected Myocardial Infarctio NCT01787110 | Karolinska Institutet | Phase 3 |
| Completed | Comparison of BIOdegradable Polymer and DuRablE Polymer Drug-eluting Stents in an All COmeRs PopulaTion (BIO-R NCT01674803 | Foundation of Cardiovascular Research and Education Enschede | N/A |
| Completed | Hemodynamics During the Soccer Championship 2012 NCT01617863 | University Hospital Schleswig-Holstein | — |
| Completed | Mersey Acute Coronary Syndrome Rule-Out Using High Sensitive Troponin NCT02581540 | Liverpool University Hospitals NHS Foundation Trust | — |
| Completed | DUrable Polymer-based STent CHallenge of Promus Element Versus ReSolute Integrity in an All Comers Population NCT01331707 | Foundation of Cardiovascular Research and Education Enschede | Phase 4 |
| Unknown | DEDICA (Dose of HEparin During Coronary Angioplasty) Trial NCT01694459 | San Filippo Neri General Hospital | Phase 4 |
| Unknown | Coronary Angioplasty in Octogenarians With Emergent Coronary Syndromes NCT02126202 | Sahlgrenska University Hospital | Phase 4 |
| Completed | Intravascular Near Infrared Spectroscopy (NIRS) Bifurcation - Lipid Core Plaque Shift Study NCT00905671 | Infraredx | Phase 4 |
| Terminated | Dalteparin Versus Unfractionated Heparin In Patients With Acute Coronary Syndrome NCT00435487 | Pfizer | Phase 4 |
| Completed | Stents, Drug Eluting Stents, and CABG- Financial and Clinical Impact. NCT00394680 | Shaare Zedek Medical Center | — |
| Completed | IMMEDIATE Trial - Out of Hospital Administration of Glucose, Insulin and Potassium. NCT00091507 | Tufts Medical Center | Phase 3 |
| Completed | Clopidogrel Optimal Loading Dose Usage to Reduce Recurrent EveNTs/Optimal Antiplatelet Strategy for Interventi NCT00335452 | Sanofi | Phase 3 |
| Completed | Advantageous Predictors of Acute Coronary Syndromes Evaluation (APACE) Study NCT00470587 | University Hospital, Basel, Switzerland | — |
| Completed | SPECTACL: SPECTroscopic Assessment of Coronary Lipid NCT00330928 | Infraredx | Phase 2 / Phase 3 |
| Completed | Study on Safety and Effectiveness of Three Doses of Argatroban as Anticoagulant in Percutaneous Coronary Inter NCT00508924 | Tanabe Pharma Corporation | Phase 2 |
| Completed | Pilot Study on Shear-induced Platelet Aggregation in Acute Coronary Syndromes NCT00299143 | Institut National de la Santé Et de la Recherche Médicale, France | — |
| Completed | Heart Function and Exercise Capacity in Patients With Hypertrophic Cardiomyopathy NCT00354328 | National Heart, Lung, and Blood Institute (NHLBI) | — |
| Completed | Omega-3 Fatty Acids to Improve Depression and Reduce Cardiovascular Risk Factors NCT00116857 | Washington University School of Medicine | Phase 3 |
| Completed | Diagnosis and Treatment of ACS in the ED: The Impact of Rapid Bedside cTnI Testing on Outcomes NCT00222352 | University of Cincinnati | — |
| Completed | At-Home Automated External Defibrillator (AED) Training Study NCT00219674 | Public Health - Seattle and King County | Phase 2 |
| Completed | Abciximab, Clopidogrel and Percutaneous Coronary Intervention in Acute Coronary Syndrome (ISAR-REACT-2) NCT00133003 | Deutsches Herzzentrum Muenchen | Phase 4 |
| Completed | Novel Method to Diagnose Acute Myocardial Ischemia NCT00285922 | University of California, San Francisco | — |
| Completed | Using Magnetic Resonance Imaging to Evaluate Heart Vessel Function After Angioplasty or Stent Placement Proced NCT00692991 | Johns Hopkins University | — |
| Completed | CARDS Is Designed To Show If Lowering Cholesterol With Atorvastatin In Type 2 Diabetics Without CV Disease Red NCT00327418 | Pfizer | Phase 4 |
| Completed | Postmenopausal Hormone Therapy in Unstable Angina NCT00000601 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 3 |
| Completed | A Study Evaluating the Efficacy and Safety of Abciximab, an Anti-Platelet Therapy, in Patients With Unstable A NCT00269906 | Centocor, Inc. | Phase 3 |
| Completed | A Study Evaluating the Efficacy and Safety of Abciximab, an Anti-platelet Therapy, in Patients Undergoing High NCT00269893 | Centocor, Inc. | Phase 3 |
| Completed | Multicenter Study of Silent Myocardial Ischemia (MSSMI) NCT00005216 | University of Rochester | — |
| Completed | Unstable Angina Pectoris Trial NCT00000486 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 3 |